Percheron Therapeutics has announced that it will investigate avicursen (ATL1102) in other indications besides Duchenne muscular dystrophy (DMD) following disappointing Phase IIb results last month.

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

DMD occurs in approximately one in every 3,500 male births. Credit: Dan76 / Shutterstock. Percheron Therapeutics has announced that it will investigate avicursen (ATL1102) in other indications besides ...

The monarch marked the 80th anniversary in Poland on Holocaust Memorial Day ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Percheron Therapeutics board addresses shareholders following failed phase 2b trial EBR’s US FDA manufacturing pre-approval inspection scheduled to start January 14 as share price rockets Regis ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The European Social Charter is a Council of Europe treaty that guarantees fundamental social and economic rights as a counterpart to the European Convention on Human Rights, which refers to civil and ...

The European stock markets have broadly underperformed their global peers, particularly Wall Street throughout the year. Several factors have contributed to this trend, including a lack of robust ...

The price of the Dutch TTF, the benchmark European natural gas climbed by more than 4% to €51 per megawatt-hour, its highest level since October 2023, before easing a little, on the first ...

Avicursen is under clinical development by Percheron Therapeutics and currently in Phase II for Duchenne Muscular Dystrophy. According to GlobalData, Phase II drugs for Duchenne Muscular Dystrophy ...

Focus on Europe presents genuine stories about the lives of real people –from the Polish blacksmith to the Finnish air traffic controller, from a British businessman to a Turkish women‘s ...